CS151744B1 - - Google Patents

Info

Publication number
CS151744B1
CS151744B1 CS357A CS35771A CS151744B1 CS 151744 B1 CS151744 B1 CS 151744B1 CS 357 A CS357 A CS 357A CS 35771 A CS35771 A CS 35771A CS 151744 B1 CS151744 B1 CS 151744B1
Authority
CS
Czechoslovakia
Application number
CS357A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CS357A priority Critical patent/CS151744B1/cs
Publication of CS151744B1 publication Critical patent/CS151744B1/cs

Links

CS357A 1971-01-19 1971-01-19 CS151744B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS357A CS151744B1 (de) 1971-01-19 1971-01-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS357A CS151744B1 (de) 1971-01-19 1971-01-19

Publications (1)

Publication Number Publication Date
CS151744B1 true CS151744B1 (de) 1973-11-19

Family

ID=5335504

Family Applications (1)

Application Number Title Priority Date Filing Date
CS357A CS151744B1 (de) 1971-01-19 1971-01-19

Country Status (1)

Country Link
CS (1) CS151744B1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074748A1 (en) 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
WO2002074750A1 (en) * 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
US7482372B2 (en) 2001-05-25 2009-01-27 Bristol-Myers Squibb Company Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074748A1 (en) 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
WO2002074750A1 (en) * 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
EP1676846A2 (de) 2001-03-15 2006-07-05 AstraZeneca AB Hydantoinderivate als MMP-Inhibitoren
US7482372B2 (en) 2001-05-25 2009-01-27 Bristol-Myers Squibb Company Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)

Similar Documents

Publication Publication Date Title
AU2658571A (de)
CS151744B1 (de)
AU2691671A (de)
AU2684071A (de)
AU2742671A (de)
AU2485671A (de)
AU2941471A (de)
AU2952271A (de)
AU3005371A (de)
AU442477B2 (de)
AU2837671A (de)
AU2927871A (de)
AU2654071A (de)
AU2669471A (de)
AU2473671A (de)
AU2684171A (de)
AU2706571A (de)
AU2724971A (de)
AU2726271A (de)
AU2740271A (de)
AU3038671A (de)
AU3025871A (de)
AU2755871A (de)
AU2963771A (de)
AU2836771A (de)